ZBTB33 and prostate cancer: Furthermore, the transcription factor Kaiso (ZBTB33) has been hypothesized to play a role in impacting mortality outcomes in people of African ancestry with cancer, due to data displaying associations between its increased expression and poor overall survival in African American individuals with breast and prostate cancer [64,65].